Antibiograms
Sunnybrook Health Sciences Centre
2021 Sunnybrook – Entire Hospital (Gram Positive and Gram Negative)
2021 Sunnybrook - Entire Hospital
Duplicate isolates within 30 days, surveillance and urine specimens excluded
*Staphylococci that test susceptible to cloxacillin are also susceptible to cefazolin
Duplicate isolates within 30 days, surveillance and urine specimens excluded
Gram Positive | Total Isolates | % of isolates susceptible | ||||||
Ampicillin | Clindamycin | Cloxacillin* | Penicillin | Doxycycline | TMP/SMX | Vancomycin | ||
Coagulase Negative Staphylococci | 208 | 60 | 42 | 93 | 69 | 100 | ||
Enterococcus faecalis | 120 | 99 | 100 | |||||
Enterococcus faecium | 55 | 39 | 78 | |||||
Staphylococcus aureus | 600 | 78 | 84 | 95 | 99 | 100 | ||
MRSA | 96 | 70 | R | 83 | 97 | 100 | ||
MSSA | 504 | 80 | 100 | 97 | 100 | 100 | ||
Viridans Streptococci | 69 | 89 | 90 | 100 |
Gram Negative | Total Isolates | % of isolates susceptible | ||||||||||
Amikacin | Ampicillin | Cefazolin | Ceftazidime | Ceftriaxone | Ciprofloxacin | Gentamicin | Meropenem | Piperacillin/tazobactam | Tobramycin | TMP/SMX | ||
Acinetobacter baumannii Complex | 40 | 100 | 80 | 85 | 95 | 95 | 78 | 90 | 90 | |||
Enterobacter cloacae complex | 117 | 100 | R | R | R | 93 | 100 | 98 | R | 99 | 97 | |
Escherichia coli | 301 | 100 | 50 | 73 | 77 | 65 | 91 | 99 | 75 | 90 | 71 | |
ESBL | 64 | 99 | R | R | R | 11 | 78 | 99 | R | 90 | 31 | |
non ESBL | 236 | 100 | 64 | 93 | 99 | 79 | 95 | 100 | 95 | 95 | 81 | |
Klebsiella aerogenes (previously known as Enterobacter aerogenes) | 49 | 100 | R | R | R | 90 | 100 | 100 | R | 100 | 100 | |
Klebsiella oxytoca | 48 | 100 | R | 79 | 92 | 92 | 98 | 100 | 92 | 95 | 96 | |
Klebsiella pneumoniae | 130 | 100 | R | 95 | 100 | 92 | 98 | 100 | 97 | 100 | 98 | |
Proteus mirabilis | 31 | 100 | 74 | 84 | 100 | 87 | 97 | 100 | 100 | 97 | 84 | |
Pseudomonas aeruginosa | 284 | 100 | R | R | 79 | 79 | 98 | 79 | 72 | 99 | ||
Serratia marcescens | 59 | 100 | 80 | 100 | 100 | 100 | 100 | |||||
Stenotrophomonas maltophilia | 46 | NA | 93 |
R = considered inherently resistant, NA = not available
2021 Sunnybrook – ICU (Gram Positive and Gram Negative)
2021 Sunnybrook - ICU
Duplicate isolates within 30 days, surveillance and urine specimens excluded
*Staphylococci that test susceptible to cloxacillin are also susceptible to cefazolin
Duplicate isolates within 30 days, surveillance and urine specimens excluded
Gram Positive | Total Isolates | % of isolates susceptible | ||||
Clindamycin | Cloxacillin* | Tetracycline | TMP/SMX | Vancomycin | ||
Coagulase Negative Staphylococci | 36 | 50 | 25 | 92 | 44 | 100 |
Staphylococcus aureus | 116 | 81 | 83 | 96 | 100 | 100 |
MRSA | 20 | 75 | R | 90 | 100 | 100 |
MSSA | 96 | 82 | 100 | 97 | 100 | 100 |
Gram Negative | Total Isolates | % of isolates susceptible | ||||||||||
Amikacin | Ampicillin | Cefazolin | Ceftazidime | Ceftriaxone | Ciprofloxacin | Gentamicin | Meropenem | Piperacillin/tazobactam | Tobramycin | TMP/SMX | ||
Enterobacter cloacae complex | 34 | 100 | R | R | R | 94 | 100 | 100 | R | 100 | 97 | |
Escherichia coli | 66 | 100 | 44 | 64 | 70 | 64 | 91 | 99 | 67 | 86 | 62 | |
ESBL | 19 | 100 | R | R | R | 11 | 78 | 99 | R | 56 | 6 | |
non ESBL | 47 | 100 | 62 | 89 | 98 | 83 | 96 | 100 | 94 | 98 | 83 | |
Klebsiella pneumoniae | 38 | 100 | R | 92 | 100 | 89 | 100 | 100 | 100 | 100 | 100 | |
Pseudomonas aeruginosa | 72 | 100 | 65 | 67 | 97 | 65 | 60 |
98 |
R = considered inherently resistant
2021 Sunnybrook – Urine (Gram Positive and Gram Negative)
2021 Sunnybrook Urine Antibiogram
Duplicate isolates within 30 days excluded
*Staphylococci that test susceptible to cloxacillin are also susceptible to cefazolin
R= Considered inherently resistant
Duplicate isolates within 30 days excluded
Gram Positive | Total Isolates | % of isolates susceptible | |||||||
Ampicillin | Cloxacillin* | Meropenem | Nitrofurantoin | Piperacillin/tazobactam | Tobramycin | TMP/SMX | Vancomycin | ||
Staphylococcus aureus | 74 | 89 | 89 | 89 | 99 | 100 | |||
MRSA | 8 | R | R | R | 100 | 100 | |||
MSSA | 66 | 100 | 100 | 100 | 98 | 100 | |||
Enterococcus spp. | 702 | 89 | 89 | 98 |
Gram Negative | Total Isolates | % of isolates susceptible | |||||||||||
Amikacin | Ampicillin | Cefazolin | Ceftazidime | Ceftriaxone | Ciprofloxacin | Gentamicin | Meropenem | Nitrofurantoin | Piperacillin/tazobactam | Tobramycin | TMP/SMX | ||
Citrobacter freundii | 39 | 100 | 87 | 97 | 100 | 95 | 97 | 97 | |||||
Citrobacter koseri | 35 | 100 | 100 | 100 | 100 | 89 | 100 | 100 | |||||
Enterobacter cloacae complex | 64 | 100 | R | R | R | 89 | 98 | 100 | 46 | R | 98 | 91 | |
Escherichia coli | 1073 | 100 | 52 | 79 | 83 | 60 | 90 | 100 | 97 | 80 | 90 | 76 | |
ESBL | 179 | 100 | R | R | R | 12 | 73 | 100 | 94 | R | 70 | 49 | |
non ESBL | 894 | 100 | 62 | 95 | 100 | 70 | 94 | 100 | 98 | 96 | 84 | 81 | |
Klebsiella oxytoca | 63 | 100 | R | 73 | 97 | 98 | 98 | 100 | 77 | 90 | 98 | 95 | |
Klebsiella pneumoniae | 241 | 100 | R | 90 | 92 | 84 | 98 | 100 | 21 | 89 | 96 | 90 | |
ESBL | 18 | 100 | R | R | R | 28 | 72 | 100 | 17 | R | 61 | 28 | |
non ESBL | 223 | 100 | R | 97 | 99 | 88 | 99 | 100 | 21 | 96 | 99 | 95 | |
Morganella morganii | 39 | 100 | 77 | 92 | 100 | 92 | 82 | ||||||
Proteus mirabilis | 124 | 100 | 81 | 94 | 100 | 89 | 94 | 100 | R | 100 | 95 | 90 | |
Pseudomonas aeruginosa | 159 | 99 | 91 | 82 | 97 | 89 | 84 | 99 |